Venture Planning Group

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:

- Market Intelligence Surveys
- Opportunity Analyses
- New Technology/Product Assessments
- Acquisition/Joint Venture Evaluations

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Found 1810 publications
Drugs of Abuse: A Analysis of the Point-of-Care Testing Market: US, Germany, Spain, Physician Offices, Emergency Rooms, Ambulatory Care Centers US$ 3,850.00

... their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for drugs of ... Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and ...

May, 2013 194 pages
2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,--Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care... US$ 4,500.00

This new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument ...

Apr, 2013 366 pages
2013 Analysis of the Point-of-Care Coagulation Testing Market: US, Germany, Spain Physician Offices, Emergency Rooms, Operating Suites, ICUs/CUs, Cancer Clinics, Ambulatory Care Centers,... US$ 7,500.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market ...

Apr, 2013 450 pages
2013 Analysis of the US Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 9,700.00

Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

Apr, 2013 620 pages
2013 Analysis of the UK Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

Apr, 2013 575 pages
2013 Analysis of the Spanish Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 565 pages
2013 Analysis of the Japanese Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 7,500.00

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $2,450. Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 590 pages
2013 Analysis of the German Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 585 pages
2013 Analysis of the Italian Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 570 pages
2013 Analysis of the French Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 585 pages
2013 Analysis of the US Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 9,800.00

Highlights Comprehensive 460-pages market segmentation analysis of the US transfusion testing market. Major issues pertaining to the US transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

Apr, 2013 460 pages
2013 Analysis of the UK Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Highlights Comprehensive 422-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the UK transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten ...

Apr, 2013 422 pages
2013 Analysis of the Spanish Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Highlights Comprehensive 425-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the Spanish transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

Apr, 2013 425 pages
2013 Analysis of the Japanese Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 7,700.00

Highlights Comprehensive 426-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the Japanese transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years ...

Apr, 2013 426 pages
2013 Analysis of the Italian Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Highlights Comprehensive 412-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the Italian transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

Apr, 2013 412 pages
2013 Analysis of the German Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Highlights Comprehensive 426-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the German transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

Apr, 2013 426 pages
2013 Analysis of the French Transfusion Diagnostic Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,100.00

Highlights Comprehensive 430-page market segmentation analysis of the transfusion testing market. Major issues pertaining to the French transfusion testing practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

Apr, 2013 430 pages
2013 Analysis of the French Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,700.00

Complete report $5,900. DataPack (test volumes, sales forecasts, supplier shares) $2,350. Highlights Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and ...

Apr, 2013 850 pages
2013 Analysis of the US Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 9,500.00

Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...

Apr, 2013 880 pages
2013 Analysis of the UK Nucleic Acid Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape US$ 6,700.00

Highlights Comprehensive 855-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...

Apr, 2013 855 pages
1 2 3 4 5 ... 91

News & Press-Releases by Venture Planning Group